TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 343 filers reported holding TANDEM DIABETES CARE INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $382,147 | -14.2% | 18,399 | +1.4% | 0.00% | -25.0% |
Q2 2023 | $445,327 | -41.1% | 18,147 | -2.6% | 0.00% | -42.9% |
Q1 2023 | $756,564 | -7.1% | 18,630 | +2.8% | 0.01% | -12.5% |
Q4 2022 | $814,539 | -2.1% | 18,121 | +4.3% | 0.01% | -11.1% |
Q3 2022 | $832,000 | -18.8% | 17,382 | +0.4% | 0.01% | -10.0% |
Q2 2022 | $1,025,000 | -48.7% | 17,309 | +0.8% | 0.01% | -37.5% |
Q1 2022 | $1,997,000 | -21.8% | 17,174 | +1.2% | 0.02% | -15.8% |
Q4 2021 | $2,553,000 | +25.3% | 16,964 | -0.6% | 0.02% | +11.8% |
Q3 2021 | $2,037,000 | +23.1% | 17,062 | +0.4% | 0.02% | +30.8% |
Q2 2021 | $1,655,000 | +9.0% | 16,991 | -1.2% | 0.01% | 0.0% |
Q1 2021 | $1,518,000 | -5.5% | 17,200 | +2.5% | 0.01% | -13.3% |
Q4 2020 | $1,606,000 | -17.9% | 16,780 | -2.6% | 0.02% | -21.1% |
Q3 2020 | $1,955,000 | +54.3% | 17,228 | +34.5% | 0.02% | +5.6% |
Q2 2020 | $1,267,000 | +57.8% | 12,807 | +2.6% | 0.02% | +28.6% |
Q1 2020 | $803,000 | – | 12,486 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 1,000,000 | $59,610,000 | 47.04% |
Prospect Capital Advisors, LLC | 127,900 | $7,624,000 | 4.68% |
Asymmetry Capital Management, L.P. | 43,559 | $2,597,000 | 4.66% |
Copernicus Capital Management, LLC | 50,000 | $2,981,000 | 3.91% |
SECTORAL ASSET MANAGEMENT INC | 341,714 | $20,370,000 | 3.04% |
FRIESS ASSOCIATES LLC | 627,225 | $37,389,000 | 2.60% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,361,345 | $81,150,000 | 2.59% |
Parkman Healthcare Partners LLC | 134,959 | $8,045,000 | 2.32% |
OBERWEIS ASSET MANAGEMENT INC/ | 109,940 | $6,554,000 | 2.18% |
First Light Asset Management, LLC | 268,574 | $16,010,000 | 2.05% |